Inventor · disambiguated record
Joyson Karakunnel
Also filed as: KARAKUNNEL JOYSON · KARAKUNNEL JOYSON J
4 granted patents·7 pending applications·7 citations·filing 2015–2023
65Inventor score
Files withARCUS BIOSCIENCES INC3MEDIMMUNE LLC3MEDIMMUNE LTD2TRISHULA THERAPEUTICS INC2NARWAL RAJESH1
Top patents by PatentIndex Score
11 records- 0185US10232040B2Anti-B7 H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancerMEDIMMUNE LLC·Filed 2015·Granted Mar 19, 2019·6 cites·36 claims
- 0278US11446377B2Anti-B7-H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancerMEDIMMUNE LLC·Filed 2019·Granted Sep 20, 2022·1 cites·13 claims
- 0371US2023115328A1Anti-B7-H1 and Anti-CTLA-4 Antibodies for Treating Non-Small Cell Lung CancerMEDIMMUNE LLC·Filed 2022·Application pending·0 cites
- 0466US2023338377A1Dosing with an azolopyrimidine compoundARCUS BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0562US11478479B2Dosing with an azolopyrimidine compoundARCUS BIOSCIENCES INC·Filed 2019·Granted Oct 25, 2022·0 cites·25 claims
- 0656US2025188165A1Combinations with an anti human cd39 antibody, an anti human pd-1 antibody, and chemotherapy in gastric cancerTRISHULA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0756US2024150487A1Combinations with an anti human cd39 antibody, an anti human pd-1 antibody, and chemotherapy in gastric cancerTRISHULA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0850US2020171149A1Combination therapy for non-small cell lung cancer positive for egfr mutationMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 0949US12433836B2Parenterally administered immune enhancing drugsARCUS BIOSCIENCES INC·Filed 2019·Granted Oct 7, 2025·0 cites·27 claims
- 1040US2018147279A1Combination therapy for non-small cell lung cancer positive for egfr mutationMEDIMMUNE LTD·Filed 2016·Application pending·0 cites
- 1129US2016060344A1Combination therapy for pd-l1 negative tumorsNARWAL RAJESH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joyson Karakunnel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →